Coronavirus: Musk says Tesla is building RNA microfactories for CureVac

Reuters


Tesla Inc (TSLA.O) is building “RNA microfactories” for coronavirus vaccine developer CureVac in Germany, the electric carmaker’s chief executive officer, Elon Musk, tweeted on Wednesday.

SpaceX owner and Tesla CEO Elon Musk arrives on the red carpet for the automobile awards “Das Goldene Lenkrad” (The golden steering wheel) given by a German newspaper in Berlin, Germany, November 12, 2019. REUTERS

Tesla Inc (TSLA.O) is building “RNA microfactories” for coronavirus vaccine developer CureVac in Germany, the electric carmaker’s chief executive officer, Elon Musk, tweeted on Wednesday.

CureVac, an unlisted German company, has said it is developing transportable, automated RNA production units that it calls printers. They will be designed to be shipped to remote locations, where they can churn out its vaccine candidate and other mRNA-based therapies depending on the recipe fed into the machine.

But for the immediate pandemic use – should its vaccine candidate win market approval – it has production sites with regulatory approval in Germany with a capacity to produce hundreds of millions of doses.

It is also building a new stationary site that could increase its output tenfold to billions of doses.

Musk did not elaborate on his plans. Tesla and CureVac were not immediately available to comment.

IndiaToday.in has plenty of useful resources that can help you better understand the coronavirus pandemic and protect yourself. Read our comprehensive guide (with information on how the virus spreads, precautions and symptoms), watch an expert debunk myths, and access our dedicated coronavirus page.
Get real-time alerts and all the news on your phone with the all-new India Today app. Download from

  • Andriod App
  • IOS App



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

x